Related Experiment Videos
A study of the effect of simultaneous vaccination with BCG and smallpox vaccine in newborn infants
Insights
Simultaneous vaccination with Bacillus Calmette-Guérin (BCG) and smallpox vaccine in newborns is safe and effective. This combined approach offers significant benefits for healthcare efficiency, especially in developing nations.
Area of Science:
- Pediatrics
- Immunology
- Public Health
Background:
- BCG and smallpox vaccinations are crucial for infant health.
- Combining vaccinations could improve efficiency and reduce costs, particularly in resource-limited settings.
Purpose of the Study:
- To evaluate the safety and efficacy of simultaneous BCG and smallpox vaccination in newborn infants.
- To determine potential interactions between the two vaccines when administered together.
Main Methods:
- 696 newborn infants in Taiwan were divided into three groups: simultaneous vaccination, BCG only, and smallpox only.
- Follow-up included assessment of vaccination lesion size, smallpox revaccination reactions, and tuberculin tests at 12 weeks.
Main Results:
- No significant differences were observed in smallpox vaccination take rates or lesion sizes between simultaneous and smallpox-only groups.
- Tuberculin tests showed normal BCG response in simultaneous and BCG-only groups, with minimal reactions in the smallpox-only group.
- Simultaneous administration did not impair the immune response to either vaccine.
Conclusions:
- There is no adverse interaction between BCG and smallpox vaccines when administered simultaneously in newborns.
- Simultaneous BCG and smallpox vaccination is a safe and viable procedure for infants, offering practical advantages.
Abstract:
In order to determine whether the BCG and smallpox vaccinations of newborn infants could be combined, thus saving staff, time and money, particularly in the developing countries, 696 newborn infants in Taiwan were divided into three groups and vaccinated by one of the following three methods: simultaneous vaccination with BCG and smallpox vaccine, vaccination with BCG only, and vaccination with smallpox vaccine only. On follow-up, no difference was observed between the "simultaneous" group and the "smallpox only" group in respect of either no-take rate and frequency distribution by size of vaccination lesions or reactions to smallpox revaccination at 12 weeks. Tuberculin tests at 12 weeks revealed a normal distribution in the size of tuberculin reactions with a mean of 11.94 mm and 12.19 mm respectively in the "simultaneous" group and the "BCG only" group; in the "smallpox only" group all the reactions were below 9 mm, the great majority being 0-3 mm. The author concludes that there is no interaction between primary BCG and smallpox vaccination when both vaccines are administered simultaneously, and that, despite the reported complications, simultaneous administration of BCG and smallpox vaccine in newborn infants is a safe procedure.